172 related articles for article (PubMed ID: 10367256)
1. Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis.
Sjöqvist U; Ost A; Löfberg R
Int J Colorectal Dis; 1999 Apr; 14(2):107-13. PubMed ID: 10367256
[TBL] [Abstract][Full Text] [Related]
2. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel disease.
Kullmann F; Fadaie M; Gross V; Knüchel R; Bocker T; Steinbach P; Schölmerich J; Rüschoff J
Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):371-9. PubMed ID: 8781908
[TBL] [Abstract][Full Text] [Related]
3. Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis.
Andersen SN; Rognum TO; Bakka A; Clausen OP
Mol Pathol; 1998 Dec; 51(6):327-32. PubMed ID: 10193513
[TBL] [Abstract][Full Text] [Related]
4. COX-2 and Ki-67 immunohistochemical markers in the assessment of long-standing ulcerative colitis associated dysplasia.
Frăţilă OC; Iliaş TI
Rom J Morphol Embryol; 2013; 54(1):143-9. PubMed ID: 23529322
[TBL] [Abstract][Full Text] [Related]
5. High proliferative activity is associated with dysplasia in ulcerative colitis.
Shinozaki M; Watanabe T; Kubota Y; Sawada T; Nagawa H; Muto T
Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S34-9. PubMed ID: 11052476
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitis.
Thor A; Itzkowitz SH; Schlom J; Kim YS; Hanauer S
Int J Cancer; 1989 May; 43(5):810-5. PubMed ID: 2654025
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
[TBL] [Abstract][Full Text] [Related]
8. Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective case-control study.
Itzkowitz SH; Young E; Dubois D; Harpaz N; Bodian C; Chen A; Sachar DB
Gastroenterology; 1996 Mar; 110(3):694-704. PubMed ID: 8608878
[TBL] [Abstract][Full Text] [Related]
9. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis.
Noffsinger AE; Miller MA; Cusi MV; Fenoglio-Preiser CM
Cancer; 1996 Dec; 78(11):2307-12. PubMed ID: 8940999
[TBL] [Abstract][Full Text] [Related]
10. [An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords].
Urano M; Iwata S; Takasu A; Mori S; Sakurai K; Katoh H; Yamamoto S; Kasahara M; Kuroda M; Hakuno T
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):395-401. PubMed ID: 8934774
[TBL] [Abstract][Full Text] [Related]
11. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
AbdElazeem MA; El-Sayed M
Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
[TBL] [Abstract][Full Text] [Related]
12. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
13. Dysplasia-like epithelial atypia in ischemic bowel disease.
Abraham SC; Taggart MW; Loftus EV; Wu TT
Hum Pathol; 2014 Jul; 45(7):1348-57. PubMed ID: 24946975
[TBL] [Abstract][Full Text] [Related]
14. Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study.
Tiniakos DG; Brunt EM
Liver; 1999 Feb; 19(1):58-68. PubMed ID: 9928768
[TBL] [Abstract][Full Text] [Related]
15. Assessment of dysplasia, mucosal mucins, p53 protein expression, and DNA content in ulcerative colitis patients with colectomy and ileorectal anastomosis.
Navratil E; Stettler C; Paul G; Vilotte J; Vissuzaine C; Mignon M; Potet F
Scand J Gastroenterol; 1995 Apr; 30(4):361-6. PubMed ID: 7610353
[TBL] [Abstract][Full Text] [Related]
16. Analysis of proliferative activity in colorectal mucosa by immunohistochemical detection of proliferating cell nuclear antigen (PCNA). Methodological aspects and application to routine diagnostic material.
Diebold J; Lai MD; Löhrs U
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):283-9. PubMed ID: 1359701
[TBL] [Abstract][Full Text] [Related]
17. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy.
Joo M; Odze RD
Am J Surg Pathol; 2010 May; 34(5):689-96. PubMed ID: 20410806
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53, bcl-2, and Ki-67 proteins in the inflammatory regenerative and dysplastic epithelial lesions of flat colonic mucosa.
Radović S; Vukobrat-Bijedić Z; Selak I; Babić M
Bosn J Basic Med Sci; 2006 Feb; 6(1):39-45. PubMed ID: 16533178
[TBL] [Abstract][Full Text] [Related]
19. DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia.
Löfberg R; Broström O; Karlén P; Ost A; Tribukait B
Gastroenterology; 1992 Apr; 102(4 Pt 1):1149-54. PubMed ID: 1551524
[TBL] [Abstract][Full Text] [Related]
20. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
